Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andrea Eisen"'
Autor:
Wendy S. Meschino, Tari Little, Kelly A. Metcalfe, Jordan Lerner Ellis, Kathy Chun, Rinku Sutradhar, Andrea Eisen, Nancy N. Baxter, Lea Velsher, Fahima Dossa
Publikováno v:
CMAJ Open
Background: Our understanding of how testing for and mutations of the BRCA1 and BRCA2 genes affect cancer risk and the use of risk-reduction strategies comes largely from studies of women recruited from specialized genetics clinics. Our aim was to as
Autor:
Tomasz Huzarski, Charis Eng, Robert Fruscio, Beth Y. Karlan, Nadine Tung, Jan Lubinski, Andrea Eisen, William D. Foulkes, Pål Møller, Joanne Kotsopoulos, Olufunmilayo I. Olopade, Jeffrey N. Weitzel, Steven A. Narod, Christian F. Singer, Susan L. Neuhausen, Louise Bordeleau, Susan Armel, Shana J. Kim, Leigha Senter
Publikováno v:
Publons
Background: Weight gain and other anthropometric measures on the risk of ovarian cancer for women with BRCA mutations are not known. We conducted a prospective analysis of weight change since age 18, height, body mass index (BMI) at age 18, and curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80103b14e7a0b3c5a4ac674eb3fa2c1
http://hdl.handle.net/10281/329852
http://hdl.handle.net/10281/329852
Autor:
Susan Armel, Nadine Tung, Robert Fruscio, Beth Y. Karlan, Steven A. Narod, Christian F. Singer, Charis Eng, Joanne Kotsopoulos, Tomasz Huzarski, Louise Bordeleau, Olufunmilayo I. Olopade, Jeffrey N. Weitzel, Susan L. Neuhausen, Jan Lubinski, William D. Foulkes, Pål Møller, Leigha Senter, Shana J. Kim, Andrea Eisen
Publikováno v:
Molecular Genetics and Metabolism. 132:S357-S358
Background: Weight gain and other anthropometric measures on the risk of ovarian cancer for women with BRCA mutations are not known. We conducted a prospective analysis of weight change since age 18, height, body mass index (BMI) at age 18, and curre
Autor:
Mohammad R. Akbari, Tracy Graham, Jeanna McCuaig, Steven A. Narod, Kelly A. Metcalfe, Frances C. Wright, Andrea Eisen, David R. McCready, Aletta Poll, Ping Sun, Tulin Cil, Alexandra Candib, Jordan Lerner-Ellis
Publikováno v:
Annals of surgical oncology. 28(4)
This study aimed to evaluate the impact of rapid genetic testing (RGT) for BRCA1 and BRCA2 at the time of breast cancer diagnosis on treatment choices. Bilateral mastectomy for the treatment of breast cancer in women with a BRCA1 or BRCA2 mutation of
Autor:
Tuya Pal, Jan Lubinski, Jacek Gronwald, Charis Eng, Andrea Eisen, Jeffrey N. Weitzel, Steven A. Narod, William D. Foulkes, Peter Ainsworth, Susan L. Neuhausen, Joanne Kotsopoulos, Leigha Senter, Nadine Tung, Henry T. Lynch, Christian F. Singer, Ping Sun
Publikováno v:
Breast cancer research and treatment. 171(2)
In the general population, an early age at first full-term birth confers protection against the risk of developing breast cancer. The relationship between age at first birth and breast cancer risk is not clear for women with a mutation in the BRCA1 o
Autor:
Leigha Senter, Beth Y. Karlan, Henry T. Lynch, Christian F. Singer, Jacek Gronwald, Susan L. Neuhausen, Andrea Eisen, Barry P. Rosen, Joanne Kotsopoulos, Steven A. Narod, Jan Lubinski, Ping Sun, Pål Møller, William D. Foulkes, Peter Ainsworth, Nadine Tung, Tomasz Huzarski
Publikováno v:
Gynecologic oncology. 150(1)
Objectives For women at high risk of developing ovarian cancer, it is important to provide an accurate recommendation for the optimal age for preventive surgery in order to maximize the preventative effect while delaying symptoms associated with earl
Autor:
Leigha Senter, Kelly A. Metcalfe, Jan Lubinski, S. A. Narod, Jacek Gronwald, Susan L. Neuhausen, Andrea Eisen, Tomasz Huzarski, William D. Foulkes, Henry T. Lynch, Christian F. Singer, Beth Y. Karlan, Jeanna M. McCuaig, Ping Sun
Publikováno v:
Clinical genetics. 93(5)
The objective of this study was to estimate the lifetime risk of breast cancer in women with a BRCA1 or BRCA2 mutation with and without at least 1 first-degree relative with breast cancer. A total of 2835 women with a BRCA1 or BRCA2 mutation were fol
Autor:
Gareth Evans, Jan Lubinski, Susan Armel, Joanne Kotsopoulos, Charis Eng, Leigha Senter, Jacek Gronwald, Henry T. Lynch, Christian F. Singer, Andrea Eisen, Nadine Tung, Steven A. Narod, Susan L. Neuhausen, Tomasz Huzarski, Kelly A. Metcalfe, Ping Sun, Jeffrey N. Weitzel, William D. Foulkes, Tuya Pal, Pål Møller, Beth Y. Karlan
Publikováno v:
Kotsopoulos, J, Huzarski, T, Gronwald, J, Singer, C F, Moller, P, Lynch, H T, Armel, S, Karlan, B, Foulkes, W D, Neuhausen, S L, Senter, L, Tung, N, Weitzel, J N, Eisen, A, Metcalfe, K, Eng, C, Pal, T, Evans, G, Sun, P, Lubinski, J, Narod, S A & The Hereditary Breast Cancer Clinical Study Group 2017, ' Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers ', Journal of the National Cancer Institute, vol. 109, no. 1 . https://doi.org/10.1093/jnci/djw177
BACKGROUND: Whether oophorectomy reduces breast cancer risk among BRCA mutation carriers is a matter of debate. We undertook a prospective analysis of bilateral oophorectomy and breast cancer risk in BRCA mutation carriers.METHODS: Subjects had no hi
Autor:
Susan Armel, Andrea Eisen, Steven A. Narod, William D. Foulkes, Sun Ping, Nadine Tung, Ganna Chornokur, Javaid Iqbal, Jacek Gronwald, Leigha Senter, Catherine M. Phelan, Peter Möller, Jan Lubinski, Peter Ainsworth, Susan L. Neuhausen, M. Llacuachaqui, Henry T. Lynch, Christian F. Singer, Charmaine Kim-Sing, Parviz Ghadirian
Publikováno v:
British Journal of Cancer
The BRCA1 and BRCA2 genes confer increased susceptibility to breast and ovarian cancers (Wooster et al, 1995; Ford et al, 1998; Satagopan et al, 2001; Thompson et al, 2001; Antoniou et al, 2003) and to a spectrum of other cancers (Struewing et al, 19
Autor:
Leigha Senter, Sun Ping, Nadine Tung, M. Llacuachaqui, Steven A. Narod, Parviz Ghadirian, Jan Lubinski, Henry T. Lynch, Christian F. Singer, Susan Armel, Eitan Friedman, Peter Ainsworth, William D. Foulkes, Charmaine Kim-Sing, Javaid Iqbal, A Ragone, Susan L. Neuhausen, Peter Möller, Andrea Eisen
Publikováno v:
British Journal of Cancer
Background: Germline mutations in BRCA1 and BRCA2 predispose to pancreatic cancer. We estimated the incidence of pancreatic cancer in a cohort of female carriers of BRCA1 and BRCA2 mutation. We also estimated survival rates in pancreatic cancer cases